2025 American Academy of Neurology Abstract Website

Disclosures for "Capturing What Matters: Patient Reported LGI1-ANTibody Encephalitis Outcome RatiNg Scale (LANTERN)"

The institution of Dr. Kelly has received research support from The Health Research Board / Wellcome Trust.
Dr. Wagner has nothing to disclose.
Dr. Ceronie has nothing to disclose.
Dr. Strippel has nothing to disclose.
Author has nothing to disclose
The institution of Adam Handel has received research support from Medical Research Council (UK). The institution of Adam Handel has received research support from UCB-Pharma. The institution of Adam Handel has received research support from MyAware.
Dr. Soltys has nothing to disclose.
The institution of Ms. Binks has received research support from Wellcome Trust. The institution of Ms. Binks has received research support from PetSavers. The institution of Ms. Binks has received research support from PetPlan. The institution of Ms. Binks has received research support from NIHR. Ms. Binks has received intellectual property interests from a discovery or technology relating to health care. Ms. Binks has received personal compensation in the range of $0-$499 for serving as a Speaker with ECTRIMS. Ms. Binks has received personal compensation in the range of $0-$499 for serving as a Speaker with Vetmeduni Wien. Ms. Binks has received personal compensation in the range of $0-$499 for serving as a Speaker with ANA. Ms. Binks has a non-compensated relationship as a Speaker with Encephalitis Society UK that is relevant to AAN interests or activities.
Dr. Irani has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for UCB, Immunovant, MedImmun, Roche, Janssen, Cerebral therapeutics, Biogen, Amgen, Argenex, Clarivate, IQVIA, BioHaven therapeutics, ADC therapeutics, Brain, CSL Behring, and ONO Pharma.. Dr. Irani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Irani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Irani has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Brain. Dr. Irani has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for LLPs. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care.
Dr. Powell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for IQVIA. Dr. Powell has received personal compensation in the range of $0-$499 for serving as a Consultant for Eli Lilly. Dr. Powell has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Quality of Life Research. The institution of Dr. Powell has received research support from FSHD Society. The institution of Dr. Powell has received research support from EuroQol Research Foundation. The institution of Dr. Powell has received research support from AstraZeneca. The institution of Dr. Powell has received research support from KMC Healthcare. The institution of Dr. Powell has received research support from Duchenne UK. The institution of Dr. Powell has received research support from Sanofi.